Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High-fat diet, obesity and prostate disease: the ATX-LPA axis?

Literature DB >> 19204739

High-fat diet, obesity and prostate disease: the ATX-LPA axis?

Prakash Kulkarni¹, Robert H Getzenberg.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2009 PMID： 19204739 DOI： 10.1038/ncpuro1311

Source DB: PubMed Journal: Nat Clin Pract Urol ISSN： 1743-4270

× No keyword cloud information.

23 in total

1. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study.

Authors: Edward Giovannucci; Yan Liu; Elizabeth A Platz; Meir J Stampfer; Walter C Willett
Journal: Int J Cancer Date: 2007-10-01 Impact factor: 7.396

2. G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway.

Authors: Ming Yang; Wendy W Zhong; Neelam Srivastava; Anthony Slavin; Jianxin Yang; Timothy Hoey; Songzhu An
Journal: Proc Natl Acad Sci U S A Date: 2005-04-18 Impact factor: 11.205

3. The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases.

Authors: Ahmed Boucharaba; Claire-Marie Serre; Julien Guglielmi; Jean-Claude Bordet; Philippe Clézardin; Olivier Peyruchaud
Journal: Proc Natl Acad Sci U S A Date: 2006-06-12 Impact factor: 11.205

4. Prevalence of overweight and obesity in the United States, 1999-2004.

Authors: Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal: JAMA Date: 2006-04-05 Impact factor: 56.272

5. Activatory properties of lysophosphatidic acid on human THP-1 cells.

Authors: F D'Aquilio; M Procaccini; V Izzi; V Chiurchiu'; V Giambra; F Carotenuto; P Di Nardo; P M Baldini
Journal: Inflammation Date: 2007-10 Impact factor: 4.092

Review 6. Fetal origins of coronary heart disease.

Authors: D J Barker
Journal: BMJ Date: 1995-07-15

7. Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia.

Authors: Yu Zeng; Yoshiyuki Kakehi; Mohammed Ahmed Abdel Muneem Nouh; Hiroyuki Tsunemori; Mikio Sugimoto; Xiu-Xian Wu
Journal: Prostate Date: 2009-02-15 Impact factor: 4.104

Review 8. Prostate growth and inflammation.

Authors: Alessandro Sciarra; Gianna Mariotti; Stefano Salciccia; Ana Autran Gomez; Salvatore Monti; Vincenzo Toscano; Franco Di Silverio
Journal: J Steroid Biochem Mol Biol Date: 2007-09-07 Impact factor: 4.292

Review 9. Mitogenic action of LPA in prostate.

Authors: Yehia Daaka
Journal: Biochim Biophys Acta Date: 2002-05-23

10. Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid.

Authors: Shinji Sakamoto; Masahiro Yokoyama; Xianghua Zhang; Kulkarni Prakash; Kaori Nagao; Takashi Hatanaka; Robert H Getzenberg; Yoshiyuki Kakehi
Journal: Endocrinology Date: 2004-02-26 Impact factor: 4.736

4 in total

1. Cyr61 is regulated by cAMP-dependent protein kinase with serum levels correlating with prostate cancer aggressiveness.

Authors: Naoki Terada; Takumi Shiraishi; Yu Zeng; Steven M Mooney; David B Yeater; Leslie A Mangold; Alan W Partin; Prakash Kulkarni; Robert H Getzenberg
Journal: Prostate Date: 2011-10-24 Impact factor: 4.104